Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. (Move&FG)

October 16, 2020 updated by: Anne G. De Volder, MD, PhD, Université Catholique de Louvain

Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. "Effets de l'entraînement Physique Intensif Sur la plasticité cérébrale, la Cognition et le Bien être Psychologique".

The investigators perform a prospective, randomized, clinical study involving students in education with mood disorders and randomized to an intensive exercise program or a control relaxation activity.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The investigators wish to document the benefit of an intensive and structured exercise program in youth with the aim to identify the most effective programs that can improve psychological well-being, especially reducing depressive and anxiety symptoms and improving self-esteem. This study targets participants aged 9 to 30 years and included in an education program (from 4th Grade to undergraduate university or college). The investigators propose to perform a prospective, randomized, clinical study involving participants with mood disorders (International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for medical coding: ICD-10-CM F32.9), anxiety (ICD-10-CM F41.9), specific learning disabilities (ADHD hyperactivity (ICD-10-CM F90.2), dyslexia-dyscalculia-dyspraxia (ICD-10-CM F81.0, F81.2, F81.81)) and healthy subjects equally distributed for confounding variables (age, gender, subclinical or clinical depressive symptoms). The participants (ambulatory or inpatients) will be enrolled either in an experimental, intensive and structured aerobic exercise regime or in a active control activity of stretching and relaxation conducted in parallel. The effects of this program will be assessed for i) psychological symptoms, using questionnaires, ii) cognitive function, particularly attention skills and executive functions, in neuropsychological tasks, and iii) physical abilities (through physical testing). To investigate the therapeutic value of exercise in the prevention of depressive and anxiety symptoms and in the treatment of mood disorders in the young student is a necessity imposed by the current outbreak of depression among adolescents and young people at school. To promote the exercise medicine based on the level of evidence in this specific domain, rigorous experimental studies must be performed. Depending on the results, a medical imaging will be proposed to participants at the end of the behavioral study. This will be a functional magnetic resonance imaging in physiological activation condition (performing a behavioral task such as a Stroop task suited to the subject's age), performed before and after intensive physical training.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Recruiting
        • Université Catholique de Louvain
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • involved in education program
  • absence of contra-indication of physical activity
  • does accept randomization
  • no history of neurological illness or brain trauma
  • no history of psychiatric illness (exclusion of psychotic symptoms)
  • absence of contra-indication to magnetic resonance imaging
  • no uncorrected sensory impairment (must understand the therapist)
  • absence of conduct disorders (violence, school bullying)

Exclusion Criteria:

  • does not provide informed consent
  • unstable diabetes
  • Body mass index above P95 (or above 30 for adults) (except medical authorization)
  • coagulation disorders
  • severe and unstable asthma
  • history of hearth malformation or heart disease
  • medical conditions prohibiting sport or contraindicating physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
The experimental, intensive exercise regime will include 50-min sessions four times a week during five weeks (for a total of about 17 hours) combining structured aerobic exercise (at least 20 minutes jogging and moderate to high intensity active games) and anaerobic lactic resistance exercise (power training with gymn weights).
Moderate to high intensity physical training
Other Names:
  • Physical training
Active Comparator: Relaxation
The control activity will include 50-min sessions four times a week during five weeks (for a total of about 17 hours) combining mindfulness, stretching and low intensity active games (breath control, proprioception, walking, social relaxation, flexibility training).
Low intensity physical activity and relaxation
Other Names:
  • Flexibility training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline psychological well-being as assessed using depression and anxiety questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Hospital Anxiety Depression Scale (HADS) in french version for all participants, mainly suitable for inpatients
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline psychological well-being as assessed using self-esteem, mood and anxiety questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
State-Trait Anxiety Inventory (STAI) in french version for all participants, mainly suitable for outpatients
at 3 weeks, at 6 weeks and through study completion, up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline psychological well-being as assessed using depression questionnaires for children
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Children's Depression Inventory (CDI) in french version
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline psychological well-being as assessed using depression questionnaires for adolescents and adults
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Beck Depression Inventory (BDI-13) in french version
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline psychological well-being as assessed using depression questionnaire for young people and adults
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Self-depression scale (SDS) in french version
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline psychological well-being as assessed using self-esteem questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Self-perception profile for children or adolescents in french version
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition : size
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Height in meters
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition : weight
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Weight in kilograms
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition as assessed in bioelectrical impedance analysis
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Body mass index (BMI) in kilograms divided by the square of the height in meters (kg/m2)
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition : body muscle ratio
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Body muscle percentage : {body muscle mass (kg) / total body mass (kg)} x 100
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition : body fat ratio
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Body fat percentage : {body fat mass (kg) / total body mass (kg)} x 100
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline physical condition as assessed using field running tests or a cycle ergometer
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months

An estimation of maximal oxygen consumption in field running test (20m-beep test).

A submaximal effort test using a cycle ergometer.

at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline cognitive function as assessed using computerized neuropsychological testing of cognitive control
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Attention and conflict resolution testing using a variant of the Eriksen Flanker task, adapted for age, in E-Prime.
at 3 weeks, at 6 weeks and through study completion, up to 6 months
Change from baseline cognitive function as assessed using computerized neuropsychological testing of inhibitory control
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
Inhibitory control testing using a go-no go test adapted in E-Prime.
at 3 weeks, at 6 weeks and through study completion, up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne G De Volder, MD, PhD, Université Catholique de Louvain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Anticipated)

November 18, 2021

Study Completion (Anticipated)

November 18, 2021

Study Registration Dates

First Submitted

October 9, 2016

First Submitted That Met QC Criteria

November 17, 2016

First Posted (Estimate)

November 22, 2016

Study Record Updates

Last Update Posted (Actual)

October 19, 2020

Last Update Submitted That Met QC Criteria

October 16, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a monocentric study. All individual participant data that allow subject identification will be kept confidential.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe